Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization by Wright, Kelly J et al.




Uropathogenic Escherichia coli flagella aid in
efficient urinary tract colonization
Kelly J. Wright
Washington University School of Medicine in St. Louis
Patrick C. Seed
Washington University School of Medicine in St. Louis
Scott J. Hultgren
Washington University School of Medicine in St. Louis
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Wright, Kelly J.; Seed, Patrick C.; and Hultgren, Scott J., ,"Uropathogenic Escherichia coli flagella aid in efficient urinary tract




2005, 73(11):7657. DOI:Infect. Immun. 
Kelly J. Wright, Patrick C. Seed and Scott J. Hultgren
 
in Efficient Urinary Tract Colonization
 Flagella AidEscherichia coliUropathogenic 
http://iai.asm.org/content/73/11/7657




This article cites 55 articles, 32 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 




arch 3, 2014 by W










arch 3, 2014 by W







INFECTION AND IMMUNITY, Nov. 2005, p. 7657–7668 Vol. 73, No. 11
0019-9567/05/$08.000 doi:10.1128/IAI.73.11.7657–7668.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary
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In the murine model of urinary tract infections (UTI), cystitis by uropathogenic Escherichia coli (UPEC)
occurs through an intimate relationship with the bladder superficial umbrella cell entailing cycles of adher-
ence, invasion, intracellular bacterial community (IBC) formation, and dispersal (fluxing) from the intracel-
lular environment. IBC dispersal is a key step that results in the spread of bacteria over the epithelial surface
to initiate additional rounds of IBC formation. We investigated the role of flagella in mediating adherence and
motility during UTI, hypothesizing that the dispersion of the IBC would be incomplete in the absence of
motility, thus interrupting the IBC pathway and attenuating the infection. Using gfp reporter fusions, the
expression of the flagellar class I flhDC and class III fliC genes was monitored to track key points of regulation
throughout the pathogenic cascade. In vitro, growth under conditions promoting motility resulted in the robust
expression of both fusions. In contrast, only the class I fusion produced significant expression throughout early
stages of IBC development including the dispersion stage. Thus, unlike in vitro modeling of motility, the
regulatory cascade appeared incomplete in vivo. Throughout IBC formation, nonmotile fliCmutants achieved
the same number of IBCs as the wild-type (wt) strain, demonstrating that flagella are neither essential nor
required for first- or second-generation IBC formation. However, in competition experiments between wt and
fliC strains, the wt was shown to have a fitness advantage in persisting throughout the urinary tract for
2 weeks, demonstrating a subtle but measurable role for flagella in virulence.
Urinary tract infections (UTI) rank third among the list of
most common bacterial infections, with approximately 4.5 mil-
lion UTI diagnosed annually (10, 55). Uropathogenic Esche-
richia coli (UPEC) is the predominant causative microorgan-
ism, accounting for 80% of all uncomplicated infections (10,
55), which are thought to occur in an ascending manner.
Pathogens colonize the periurethral area, are introduced into
the urinary tract, ascend the urethra into the bladder to cause
cystitis, and ascend the ureters to reach the kidneys, producing
pyelonephritis. The mechanism of ascension is currently un-
known; however, motility may play a role, and flagella are
reasonable candidates to participate in the ascending process.
Flagella may also have an important role in the complex life
cycle of UPEC in the bladder. In a well-established UTI mouse
model (34) in which bacteria are directly inoculated into the
bladder, bypassing the urethra, UPEC invades superficial um-
brella cells in a type 1 pilus-mediated process (27, 33, 36, 42).
Due to the limitations of this model, any role that flagella may
play in ascending from the perianal region to the periurethrum
would not be observed. Invasion of E. coli into superficial
umbrella cells activates a complex series of events leading to
the formation of intracellular bacterial communities (IBCs), a
protected niche with biofilm-like properties (1, 34). IBCs pro-
tect UPEC from innate host surveillance and defenses, antibi-
otic treatment, and clearance by micturition (34, 35). IBCs
undergo a defined maturation and differentiation program cul-
minating in the dispersal of UPEC from infected host cells
(fluxing), upon which the bacteria are able to initiate further
rounds of binding, invasion, and IBC formation in naı¨ve cells
(21). Thus, IBC maturation is a process that is analogous to the
growth of extracellular biofilms. Reentry of fluxed bacteria into
the IBC developmental cascade is marked by slower kinetics.
Ultimately, bacterial replication ceases, and a quiescent reser-
voir or persistent state is established in the bladder tissue that,
in response to unknown signals, can reactivate and trigger a
recurrent bacteruria (35).
Recently, the visual details of IBC dispersal were deter-
mined using high-resolution time lapse video microscopy (21).
Green fluorescent protein (GFP)-producing UPEC bacteria
were observed to detach and flux from mature IBCs at 16 h
postinfection and spread throughout the bladder, thus infer-
ring a role for flagellum-mediated motility. Flagellum-medi-
ated motility is conserved among UPEC strains, with 70% of
clinical isolates obtained from women with acute, asymptom-
atic, or recurrent urinary tract infections demonstrating motil-
ity when grown in semisolid agar (K. Dodson, personal com-
munication). Furthermore, flagella are known to play a role in
Proteus mirabilis uropathogenesis (4, 41). Flagellar mutants of
P. mirabilis are deficient in in vitro catheter-associated biofilm
formation and also exhibit attenuated host urinary tract colo-
nization (4, 19, 20). In addition to these roles, flagella function
as adhesive and invasive organelles for some enteropathogenic
E. coli (EPEC) strains (12) and Salmonella species, respec-
tively (43, 51). With putative roles in adherence, ascension,
biofilm formation, and dispersal, such as that of the IBCs, we
hypothesized that flagella contribute to UPEC virulence dur-
ing urinary tract infections.
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Box 8230, Washington University School of Medicine,
660 S. Euclid Ave., St. Louis, MO 63110. Phone: (314) 362-6772. Fax:
(314) 362-1998. E-mail: hultgren@borcim.wustl.edu.





arch 3, 2014 by W







In a series of experiments using a combination of reporter
fusions and flagellar mutants, we show that, in contrast to in
vitro expression, flagellar gene expression during the IBC path-
way does not proceed to completion through the hierarchical
regulatory steps, resulting in termination between class I and
class III gene expression. Our experiments demonstrate that
IBC formation, development, and dispersal do not require
flagella. Although a prominent role for flagella is unclear in the
most acute steps of cystitis, we show that flagella contribute to
UPEC persistence in the bladder and kidney by use of a com-
petition experiment between wild-type (wt) and fliC strains
whereby the wt strain significantly outcompeted the flagellar
mutant at 2 weeks postinfection. These data are consistent with
studies by Lane et al., who have independently and concomi-
tantly found increased fitness of another UPEC strain in com-
parison with an isogenic fliC mutant at 3 days postinfection
(24). We conclude that while flagella do not play a central role
in IBC development and dispersal, they enhance the fitness of
UPEC throughout the urinary tract.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The strains used in this study are
shown in Table 1. UTI89, a cystitis-derived isolate of serotype O18:K1:H7, has
been described previously (35). Bacterial strains were grown using standard
techniques. For all in vitro and in vivo studies, overnight (typically 16-h), aerated
cultures were diluted 1:250 into fresh Luria-Bertani (LB) broth and grown
statically at 37°C for 20 to 24 h to induce type 1 piliation. Antibiotics and
supplements were used at the following concentrations where appropriate (for
K-12 and UTI89 strains, respectively): spectinomycin, 37.5 and 50 g/ml; kana-
mycin, 25 and 50 g/ml; chloramphenicol, 20 g/ml; and 5 mM L-()-arabinose.
Construction of UTI89 attHK022::COM-GFP. A GFP-marked isogenic deriva-
tive of UTI89 was constructed as follows. Plasmid pCOM-GFP (6) was digested
with MluI and SphI to obtain a fragment of approximately 1.1 kb containing gfp
under the control of the tac promoter; this fragment was ligated into compatibly
cut pAH70 (15) to create pAH70-COM-GFP (Table 1). This vector was subse-
quently electroporated into MG1655/pAH69 (15), expressing the HK022 phage
integrase. Chromosomal integrants were selected on LB-kanamycin (25 g/ml)
plates. Strains were screened via PCR for single-copy integration using combi-
nations of primers P1 to P4 (Table 2). A single-copy integrant was chosen for P1
lysis and transduction of the HK locus into UTI89, creating strain UTI89
attHK022::COM-GFP.
Construction of a nonmotile UPEC mutant. UTI89 fliC was constructed
according to the method of Datsenko and Wanner (7) using primers FLiCKO1
and FliCKO2 (Table 2) and the template pKD4 (7) to first delete the fliC gene
in MC4100 (16). Gene deletion was confirmed with the fliC-flanking primers
FliC 1 and FliC 2 (Table 2). UTI89 was transduced with a P1 lysate derived from
MC4100 fliC, followed by excision of the kanamycin cassette by introduction of
the Flp recombinase-expressing vector pCP20 (7). To facilitate microscopy, the
fliC derivative was marked by GFP expression using transduction with a P1
lysate strain prepared from MG1655 attHK022::COM-GFP. The final strain is
referred to as UTI89 fliC.
Construction of gfp reporter strains. For construction of the gfp expression
vector pPSSH10-1 (Table 1), the 750-bp SmaI fragment from pGREEN-TIR
(31) containing gfp was ligated into SpeI-cut, filled-in, and calf intestinal phos-
phatase-treated pCD13SK (37) to produce a pir-dependent vector carrying the 
att site with versatile multicloning sites upstream of gfp.
pPSSH10-1 and its derivatives were integrated into MG1655 (30) at the  att
site using integrase (Int) expressed from vector pINT-TS (15) and selected on
LB-spectinomycin (37.5 g/ml) plates. Clones were tested by PCR for single-
copy integration at the lambda phage attachment site using primer pairs AB, AC,
BD, and CD (Table 2) (37). UTI89 was transduced with a P1 phage lysate of
MG1655 att::PSSH10-1 and selected on LB-spectinomycin (50 or 100 g/ml)
plates to create UTI89 att::PSSH10-1. An additional PCR was performed as
described above for confirmation of the new locus posttransduction.
pfliC construction. pfliC, an L-()-arabinose-inducible flagellin expression
vector, was constructed as follows. fliC was amplified from UTI89 genomic DNA
by PCR (Platinum Pfx; Invitrogen) with primers FliC 3 and FliC 4, restriction
endonuclease digested with NcoI and BglII, ligated into compatibly digested
pBAD33 (13), and confirmed by restriction endonuclease digestion and DNA
sequencing. pfliC (Table 1) and pBAD33 were individually transformed into
UTI89 fliC by electroporation to create the complemented (UTI89 fliC/pfliC)
and vector control (UTI89 fliC/pBAD33) strains, respectively.
TABLE 1. Bacterial strains and plasmids
Strain or plasmid Relevant genotype or features Resistance(s) Reference
Strains
MC4100 Escherichia coli K-12 16
MG1655 Escherichia coli K-12 30
UTI89 Escherichia coli cystitis isolate 35
UTI89 UTI89 attHK022::COM-GFP Kan
r This work
UTI89/pVC UTI89 attHK022::COM-GFP/pBAD33 Kan
r Cmr This work
UTI89 fliC UTI89 fliC kanR attHK022::COM-GFP Kan
r This work
UTI89 fliC/pfliC UTI89 fliC kanR attHK022::COM-GFP/pBAD33-fliC Kan
r Cmr This work
UTI89 fliC/pVC UTI89 fliC kanR atthk::comGFP/pBAD33 Kan
r Cmr This work
UTI89 promoterless GFP UTI89 att::PSSH10-1 Spec
r This work
UTI89 class I GFP UTI89 att::PflhDC-GFP Spec
r This work
UTI89 class III GFP UTI89 att::PfliC-FliC1-15aa-GFP Spec
r This work
Plasmids
pCom-GFP Source of Ptac-gfp 6
pGREEN-TIR Source of gfp 31
pAH69 HK022 integrase expression plasmid 15
pAH70 HK022 attachment integration plasmid 15
pAH70-COM-GFP pAH70 with Ptac-gfp This work
pKD4 Antibiotic cassette template for red recombinase-mediated knockout 7
pKD46 Red recombinase expression plasmid 7
pCP20 Para-flp; ara-inducible Flp recombinase expression plasmid 7
pCD13SK Lambda attachment integration vector 37
pPSSH10-1 pCD13SK with promoterless gfp This work
pINT-TS Lambda integrase expression 15
pVC pBAD33; control vector Cmr 13
pfliC pBAD33 with Para-fliC; Ara-inducible fliC expression Cm
r This work
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Hemagglutination assay for type 1 piliation. Strains were grown statically at
37°C for 24 h as described above to induce production of type 1 pili. Hemag-
glutination assays with guinea pig erythrocytes (Colorado Veterinary Products)
were performed according to published protocols (18). Results are representa-
tive of three independent experiments.
Western blotting. For immunoblot analysis of bacterial strains, gels were
prepared as follows. Equivalent numbers of cells (108) from 24-h static cultures
were suspended in 1 Laemmli buffer (23), acidified with 1 M hydrochloric acid,
boiled for 3 to 5 min, neutralized, and resolved by 15% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. Proteins were transferred to nitrocellulose
membranes by semidry electroblotting (Bio-Rad), blocked, probed with either an
anti-FimCH (type 1 pilus marker; a kind gift from H. Mobley) or an anti-H7
(flagellar marker; Difco) antiserum followed by alkaline phosphate-conjugated
anti-mouse or anti-rabbit whole-molecule immunoglobulin G, and incubated
with CDP-Star (Tropix, Bedford, MA). Finally, specific proteins were visualized
by exposure to photographic film.
Motility assay. Strains were stabbed into 0.25% LB agar supplemented with
2,3,5-triphenyltetrazolium chloride to better visualize motility, grown at 37°C for
20 h, and qualitatively assessed for motility. When necessary, LB agar was
supplemented with antibiotics alone or with both antibiotics and L-()-arabinose
to maintain plasmids or induce expression, respectively. To quantify motility,
radii of motility circles were measured for all strains at 8 h postinoculation; then
areas of swimming were calculated by the formula A  r2, normalized to the
area of motility of UTI89, and expressed as a percentage of the motility
of UTI89.
EM and negative staining. Strains were cultured as described under “Bacterial
strains and culture conditions” above and were prepared for electron microscopy
(EM) as follows. Bacteria were allowed to be absorbed onto Formvar-carbon-
coated copper grids for 1 min. Grids were washed in distilled H2O and stained
with 1% aqueous uranyl acetate (Ted Pella Inc., Redding, CA) for 1 min. Excess
liquid was gently wicked off, and grids were allowed to air dry. Samples were
viewed on a JEOL 1200EX transmission electron microscope (JEOL USA,
Peabody, MA) at an accelerating voltage of 80 kV.
Construction of chromosomal promoter-GFP fusion strains. To permit visu-
alization of the flhDC (class I flagellar genes) and fliC (class III flagellar gene)
promoters in vivo, transcriptional gfp fusions were constructed. The promoter
regions were identified based on published data (45, 47) and amplified from
UTI89 genomic DNA using primer pairs FlhDC1-FlhDC2 and FliC5-FliC6.
Amplicons were restriction endonuclease digested and cloned into the ClaI/
BamHI or HindIII/BamHI site of pPSSH10-1 (for class I and class III, respec-
tively) using standard cloning techniques. The amplified products were se-
quenced for confirmation. Integrations of each fusion into MG1655 and P1
transduction into UTI89 were performed as described above. For construction of
a class III translational fusion, a two-step PCR was used to fuse the fliC promoter
and the first 45 nucleotides of fliC coding sequence to the entire coding sequence
of gfp using primers FliC7 to FliC10. The class III translational fusion UTI89
strain was prepared by integration and P1 transduction as above.
Mouse infections. Seven- to eight-week-old wild-type C3H/HeN female mice
were obtained from Harlan Sprague-Dawley. Twenty-four-hour static cultures of
the UTI89, UTI89 fliC, UTI89 class I GFP, or UTI89 class III GFP strain were
pelleted by centrifugation at 3,000  g for 15 min and resuspended in sterile
phosphate-buffered saline (PBS) to a concentration of 2  108 CFU/ml. For
competition experiments, UTI89 and UTI89 fliC at 2  108 CFU/ml were
mixed at a ratio of 1:1. Mice were anesthetized by inhalation of isoflurane and
infected via transurethral catheterization with 50 l of the bacterial suspension
(1  107 to 2  107 CFU). At the indicated times postinfection, mice were
sacrificed by cervical dislocation under anesthesia, and the bladders were imme-
diately harvested and processed either for microscopy or for bacterial titer
determinations as described in the next two sections.
Confocal microscopy. For in vivo transcriptional profiling of class I and class
III promoter-gfp fusion strains, infected bladders were harvested at the indicated
times, bisected, splayed by pinning under sterile PBS, gently washed with PBS,
fixed with 3% paraformaldehyde (PFA; EM grade; EMS)-PBS for 45 to 60 min
at room temperature protected from light, washed with PBS, and stained with
TO-PRO-3 iodide. For in vivo IBC imaging, bladders infected with UTI89 or
UTI89 fliC were bisected, splayed by pinning under sterile PBS, gently washed
with sterile PBS, stained with Alexa Fluor 633-conjugated wheat germ agglutinin
(WGA) (Molecular Probes), washed with PBS, and fixed with 3% PFA (EM
grade; EMS)-PBS as described above. Prepared bladders were mounted in a
large drop of antifade (Prolong; Molecular Probes) and a coverslip placed on
top. Microscopy was performed on a Zeiss (Thornwood, NY) LSM 510 Meta
Laser Scanning inverted confocal microscope using a 63 oil immersion objec-
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and images were acquired using accompanying Zeiss software. GFP was imaged
at 488-nm excitation and 505- to 530-nm emission. TO-PRO-3 iodide (Molecular
Probes) was imaged at 633-nm excitation with emission filters collecting between
the wavelengths of 650 and 690 nm. Alexa Fluor 633-conjugated WGA was
imaged at 633 nm excitation with emission filters collecting between 650 and
800 nm.
Tissue bacterial titer determinations. To enumerate the bacteria present,
bladders and kidneys were aseptically harvested 2 weeks postinfection, homog-
enized in PBS containing 0.025% Triton X-100, serially diluted, and plated onto
LB agar plates. CFU was enumerated after 24 h of growth at 37°C. For compe-
tition experiments, the relative bacterial loads for wild-type and mutant bacteria
were determined by replica plating onto LB and LB-kanamycin (50 g/ml)
plates. Total CFU was determined from LB plates, and the number of kanamy-
cin-resistant (nonmotile UTI89 fliC) CFU was determined for bacteria that
grew on LB-kanamycin (100 g/ml) plates. Kanamycin-sensitive CFU (wild-type
UTI89) represents bacteria that do not grow on LB-kanamycin (100 g/ml)
plates. Competition indices (CI) were calculated similarly to Freter et al. (11) by
using UTI89 as the reference strain, as follows: CI  (CFUUTI89/CFUUTI89 fliC
recovered from mice)/(CFUUTI89/CFUUTI89 fliC present in the initial in-
oculum).
Statistical analysis. CFU/bladder or CFU/pair of kidneys was calculated as
described in “Tissue bacterial titer determinations” above and analyzed for
significance using the nonparametric Mann-Whitney U test (InStat; GraphPad
Software) to compare bladder and kidney colonization levels between wt UTI89
and UTI89 fliC.
RESULTS
Temporal and spatial expression of class I and class III
flagellar genes in vitro and in vivo. Flagella are produced from
more than 40 genes which are organized into hierarchal classes
defined by sequence of activation (5, 48). Class I genes, flhDC,
encode the master regulator of flagellar biosynthesis and are
activated first in response to various environmental cues. Class
II and class III genes are activated subsequently. To determine
if flagella are expressed during IBC formation, strains carrying
single-copy chromosomal gfp reporter fusions to class I and
class III flagellar genes were monitored during acute cystitis.
Expression of flhDC and fliC, class I and class III flagellar
genes, respectively, was chosen because flhDC has been shown
in vitro to be the checkpoint for activation of and commitment
to flagellar biosynthesis (48), and fliC encodes a highly abun-
dant class III gene product and thus was expected to be de-
tectable in vivo. The reporter fusions were integrated at the 
att site for stability, single copy number, and avoidance of the
native gene loci where insertions may perturb expression. Prior
studies (unpublished data) show that integration at this site
does not adversely affect UTI pathogenesis.
The gfp reporter fusion strains were initially analyzed in vitro
to ensure that gfp expression correctly correlated with the
motile, flagellum-positive phenotype and that the strains re-
sponded appropriately to environmental signals known to in-
fluence motility, including glucose and temperature (25). Mo-
tility and flagellar gene expression were demonstrated to be
repressed as a function of increasing temperature and elevated
glucose concentrations. Each fusion-bearing strain exhibited
wild-type motility in LB or minimal medium soft agar and, like
the wt unmodified strain, repressed motility in minimal me-
dium in the presence of 1.5% glucose (data not shown). Fluo-
rometry measurements of the class I promoter fusion strain
relative to the promoterless reporter strain yielded a 5.5-fold
reduction in GFP fluorescence for growth at 37°C versus 25°C
on LB agar plates. However, under all of the conditions as-
sayed, the fluorescence of the class III reporter strain was
never significantly greater than that of the promoterless gfp
control strain (data not shown). We hypothesized that UTI89
may produce low levels of fliC transcript coupled with efficient
translation. Thus, a fliC::gfp translational reporter strain was
constructed by fusing the promoter, ribosome binding site, and
codons 1 to 15 of fliC to codon 2 of gfp. GFP production was
strongly evident in this strain during growth favoring motility
(0.25% motility agar) but not under repressive conditions
(shaken growth, LB) (data not shown). Epifluorescent and
light microscopy further confirmed that fliC::gfp expression
correlated with motility. These in vitro data validated and
demonstrated the accuracy and robustness of the UTI89 flhDC
transcriptional and fliC translational gfp reporter strains for in
vivo studies.
The bladders of mice infected transurethrally with the flagel-
lar gene-specific and promoterless gfp fusions were examined
at time points through the course of acute infection represent-
ing different stages of primary and secondary IBC develop-
ment: 6 h for early-stage, 16 h for mid- to late-stage, and 30 h
for second-generation IBCs. At 6 h postinfection, flhDC ex-
pression was heterogeneous among different IBCs, ranging
from entire IBCs lacking expression (Fig. 1A) to IBCs contain-
ing small GFP-positive populations adjacent to those with
abundant expression involving most of the bacteria (Fig. 1B).
Of early-stage IBCs containing the flhDC-gfp strain, roughly
50% were highly active. Three-dimensional reconstruction of
Z stack images facilitated the complete examination of each
IBC for reporter expression. At 16 h postinfection, flhDC-gfp
expression within all IBCs observed was uniformly active and
robust (Fig. 1D and E). At both 6 (Fig. 2A to C) and 16
(Fig. 2D to F) hours, fliC-gfp expression was not observed
within IBCs, although the surface bacteria and filaments
(fluxed organisms) (Fig. 2D) exhibited background fluores-
cence. At 30 h postinfection, 76% of IBCs observed (75/99)
were completely inactive (Fig. 2G), 20% (20/99) contained a
minority of GFP-positive bacteria (Fig. 2H), and 4% (4/99)
had a mixed population of randomly distributed GFP-positive
bacteria throughout the IBC (Fig. 2I). At both 6 and 16 h, the
promoterless reporter showed no appreciable emission
(Fig. 1C and F). The lack of overlapping expression profiles by
comparison of the class I and class III fusions at these time
points implied that the flagellar regulatory cascade is incom-
plete without a commitment to the expression of the structural
components required for functional flagella. As a consequence,
these data suggest that flagella may not perform a critical role
in these early steps of acute cystitis.
In vitro characterization of UTI89 fliC. If the conclusions
from the prior experiments were valid, namely, that flagella are
not widely expressed during IBC development, dispersal, or
luminal colonization, then nonmotile strains should yield sim-
ilar burdens of bacteria and numbers of IBCs during the same
time frame. We subsequently produced a flagellum-null iso-
genic derivative of UTI89 to test this hypothesis. The flagellum
is a proteinaceous organelle powered by an ATP-dependent
motor that propels the bacterium forward during the swim
phase of swim-tumble cycles of flagellum-mediated motility
(17). The flagellar filament is composed of the major structural
subunit, flagellin (or FliC), and its deletion renders the bacte-
rium nonmotile (25). We sought to engineer a completely
immotile strain and validate its phenotype in vitro; thus, fliC
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was targeted for complete in-frame deletion to determine
the role of flagellum-mediated motility during UPEC patho-
genesis.
Immunodetection of flagella in strains grown under motility-
inducing conditions using H7 anti-flagellin sera showed that
the fliC strain did not produce flagellin while the wt and
complemented strains did (Fig. 3C). While the growth of the
different strains was unaffected in both single and mixed (1:1)
growth curves (data not shown), fliC was nonmotile com-
pared to the highly motile wt parent in 0.25% LB agar
(Fig. 3A). Complementation of fliC with fliC expressed in
trans, but not with the control vector, restored motility to
60% of UTI89 levels, thus confirming that loss of motility
was due to the absence of fliC and not to a polar effect on
downstream gene expression (Fig. 3B). Flagella and pili have
been suggested to be reciprocally regulated (26). Since type 1
pili are required for adherence and invasion in cystitis, we
ensured that the deletion of fliC would not adversely affect type
1 production. Anti-FimCH antisera revealed in an immunoblot
that adhesive pili were expressed in the fliC strain. In addi-
tion, the cultures were hemagglutination positive (and man-
nose inhibitable), and EM analysis with negative staining on
24-h static LB broth cultures revealed pili on both wt and fliC
strains (Fig. 3D to G). In addition, pili and flagella were ex-
pressed simultaneously on individual bacteria. These studies
argued strongly that type 1 pilus expression was not affected by
the flagellar mutation. These data, like those of the reporter
strain experiments, emphasize the marked regulatory differ-
ences between K-12 laboratory strains and UPEC isolates.
UTI89 fliC and IBC maturation during acute cystitis. To
determine whether flagella play a role in the IBC developmen-
tal cascade, the ability of UTI89 fliC to form IBCs was ana-
lyzed relative to that of UTI89 at 6 (early IBC), 16 (mid- to late
IBC), and 30 (predominantly second-generation IBC) hours
during the acute phase of murine cystitis. Confocal imaging of
the infected, splayed bladders showed that UTI89 fliC
FIG. 1. In vivo flhDC (class I flagellar gene) transcriptional activity. The bladders of mice infected with 107 bacteria of either the UTI89 class
I GFP strain (UTI89 att::PflhDC) (A, B, D, and E) or the UTI89 promoterless GFP reporter strain (UTI89 att::PSSH10-1) (C and F) were
collected 6 (A to C) or 16 (D to F) hours postinfection, splayed by pinning, fixed with PFA, stained with TO-PRO-3 iodide (nuclear stain; red),
and imaged by confocal microscopy at 63 magnification. Yellow/green staining indicates active transcription. Red staining indicates no
transcription. Bar, 10 m. White arrows indicate autofluorescent vacuoles normally present in superficial facet cells. The UTI89 class I GFP
reporter strain resulted in both transcriptionally active and inactive IBCs at 6 h and only active IBCs at 16 h, whereas the control, UTI89
promoterless GFP strain exhibited background GFP levels at both time points.
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formed IBCs at each time point (Fig. 4D to F) grossly indis-
tinguishable in both morphology and number from the wt IBCs
(Fig. 4A to C). These data suggest that the flagellar filament
does not have an essential role in primary or secondary IBC
formation and maturation. These data also demonstrate that
motility is not essential for host colonization during acute in-
fection in this murine model.
Flagella and persistent cystitis. Although the flagellum was
not required for the acute steps of cystitis, including IBC for-
mation, we hypothesized that it may provide an advantage at
FIG. 2. In vivo fliC (class III flagellar gene) transcriptional activity. The bladders of mice infected with 107 UTI89 class III GFP bacteria (UTI89
att::PfliC-FliC1-15aa-GFP; translational fusion) were collected 6 (A to C), 16 (D to F), or 30 (G to I) hours postinfection, splayed by pinning, fixed
with PFA, stained with TO-PRO-3 iodide (nuclear stain; red), and imaged by confocal microscopy at 63 magnification. Yellow/green staining
indicates active transcription. Red staining indicates no transcription. Bar, 10 m. White arrow indicates autofluorescent vacuoles normally present
in superficial facet cells. Open arrowhead indicates GFP-positive bacteria. The UTI89 class III GFP reporter strain resulted primarily in
transcriptionally inactive IBCs; however, transcriptionally active bacteria were detected in IBCs from bladders harvested 30 h postinfection.
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FIG. 3. In vitro characterization of the nonmotile UPEC strain UTI89 fliC. (A) Motility analysis of UTI89 fliC, UTI89 fliC/pfliC, and
UTI89 fliC/pVC. Strains were grown statically in LB broth and analyzed relative to the similarly grown wild-type UPEC strain UTI89 and
UTI89/pVC for motility in 0.25% LB agar alone or supplemented with chloramphenicol (pfliC- and pVC-containing strains). Wells on the right
contain 5 mM L-()-arabinose, in contrast to the center wells, in which strains are grown without arabinose. (B) Quantified motility. Motility was
measured as described in Materials and Methods. (C) Flagellin (H7) immunoblot analysis. Lane 1, UTI89; lane 2, UTI89 fliC; lane 3, UTI89
fliC/pfliC without arabinose; lane 4, UTI89 fliC/pfliC with arabinose; lane 5, UTI89 fliC/pVC without arabinose; lane 6, UTI89 fliC/pVC with
arabinose. MW, molecular weight (in thousands). (D and E) Negatively stained electron micrographs of wild-type UTI89 (D) and UTI89 fliC (E).
Arrows indicate pili, and the arrowhead indicates the flagellum. (F) Guinea pig erythrocyte hemagglutination (HA). (G) Representative FimCH
immunoblot (n  6). Left lane, UTI89; right lane, UTI89 fliC.
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later time points in the pathogenic cascade, namely, reservoir
formation or spread to the kidney. Single infections with
UTI89 or UTI89 fliC produced equivalent bladder (P 
0.5476) and kidney (P  0.3095) colonization at 2 weeks
postinfection (Fig. 5A). However, competition experiments at
2 weeks postinfection demonstrated a competitive advantage
of the wild-type bacteria over nonmotile fliC mutant UPEC
in both bladder and kidney colonization. A 20-fold-lower blad-
der titer was seen for the nonmotile fliC mutant than for a
competing wild-type strain. This defect was even more pro-
nounced in the kidney, yielding a kidney titer for UTI89 fliC
300-fold-lower than that for UTI89. Using competition tissue
titers, competition indices were calculated (see Materials and
Methods) for each sample and “averaged” by determining the
geometric mean for each group. By definition, a competition
index of 
1 indicates outcompetition of the mutant strain
(UTI89 fliC) by the wild-type reference strain (UTI89).
A competition index equal to 1 indicates no difference in col-
onization, and a competition index of 1 indicates outcompe-
tition of the wild-type reference strain (UTI89) by the mutant
(UTI89 fliC). Geometric mean CI were calculated to be 19
for bladders and 140 for kidneys (Fig. 5B), indicating that the
wt strain outcompetes the isogenic nonmotile fliC derivative.
These data show that flagella and motility confer a fitness
advantage in persistence throughout the urinary tract.
DISCUSSION
Urinary tract infections occur as a continuum of steps by
ascension of UPEC from the perineum through the urethra to
the bladder, passing though the ureters to the kidneys. Clini-
cally, the symptoms of cystitis, dysuria, and frequency often
precede those of upper tract disease such as flank pain and
chills. The bladder is a key intermediate or end organ of dis-
ease where UPEC can adhere via type 1 pili and amass (27, 33,
36, 42). UPEC bacteria, however, do not reside exclusively in
the lumen of the bladder but instead rapidly gain access to the
epithelium, where they proliferate in an intracellular sanctu-
ary, protected from the massive inflammation associated with
cystitis (34, 35). Their intracellular proliferation results in com-
FIG. 4. IBC formation by the wild-type UPEC strain UTI89 and the nonmotile UPEC strain UTI89 fliC as a function of time. The bladders
of mice infected with either wild-type UTI89 (A to C) or the nonmotile UPEC strain (D to F), UTI89 fliC, were collected 6 (A and D), 16 (B
and E), and 30 (C and F) hours postinfection, splayed by pinning, stained with Alexa Fluor 633-conjugated WGA, fixed with PFA, and imaged by
confocal microscopy at 63 magnification. Bar, 10 m. Green staining indicates bacteria. Yellow staining indicates autofluorescent vacuoles. Red
staining indicates WGA localization. IBCs arising from the nonmotile UPEC strain UTI89 fliC were indistinguishable from those arising from
the wild-type strain UTI89 at all acute cystitis time points examined.
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munal formations with biofilm-like properties—the IBCs. The
bacteria thrive tightly enmeshed in the protective matrix of the
IBC within the host epithelium. Ultimately, they need to be
released and dispersed in order to exit the infected cell and
find new naı¨ve cells for residence. The dispersion and the
exiting of the host cell are, therefore, central steps in the
UPEC life cycle in the bladder (termed the IBC pathway).
Flagella play a key role in the living dynamic of biofilms,
having a strong influence over the ultrastructure and spread of
biofilms (22, 38, 50). In Pseudomonas aeruginosa biofilms, non-
motile strains produce greater local biomasses but less surface
coverage (22). Biofilm formation on living tissues may be even
more dependent on motility, since the adherent surface may be
dynamic, including the death or loss of the host tissue engaged
in the interaction. The luminal surface of an infected bladder
shows bacteria distributed widely but not equally over the
epithelium (34, 35). While some bacteria reside singly, most
are in small formations of clusters akin to early biofilm forma-
tion. The complex molecular cross talk at the host-pathogen
interface likely influences the biofilm pathway, igniting genetic
programs that differ from biofilm formation on an innate sur-
face. Assimilating our knowledge of luminal colonization and
the IBC pathway, we reasoned that flagella may play a role in
multiple steps of UTI pathogenesis by assuming a central role
in virulence during cystitis. We approached the problem by
first evaluating if flagellar gene expression was active during
cystitis, anticipating that this expression may correlate with a
role in pathogenesis, and then examining the impact of the loss
of motility on the course of cystitis.
Using promoter-gfp fusions to the class I-regulated flhDC
operon and the class III-regulated fliC gene, we found that the
fusions were highly active under in vitro conditions that pro-
mote motility. We found, however, that in contrast to findings
of in vitro studies involving laboratory E. coli strains, fliC tran-
scription in our prototypic UPEC strain, UTI89, is minimal
even under optimal induction of motility. UTI89 seems to have
modified its regulation, relying on efficient translation or in-
creased stability of fliC transcripts to ensure the production of
the abundant flagellin required for the assembly of flagella. In
vivo, the class I genes were robustly and homogeneously tran-
scribed within IBCs by 16 h postinfection; however, the expres-
sion of fliC could be detected within only 26% of the IBCs
observed, arguing that the commitment to make flagella, as
evidenced by the robust expression of class I genes, is inter-
rupted or at least delayed in vivo. Class III genes may in fact be
expressed in bacteria within IBCs; however, the expression
may be transient or may be produced at time points not ex-
amined in this study, either of which possibilities would ac-
count for the infrequent detection of class III genes.
The regulation of flagellar expression is arguably the most
complex network of genes and environmental inputs mapped
in prokaryotes. The production of flagella is the culmination of
environmental cues, such as pH, osmolarity, temperature, and
cyclic AMP, intersecting with the hierarchical stages of expres-
sion. Thus, the differential expression of different gene classes
may provide insights into the physiology of individual bacteria
and the IBC as a whole. In addition to highlighting the phys-
iological status of the bacteria and IBC, these studies are novel
and represent the first in vivo flagellar class I and class III gene
profiling. Our observed activation of the class I flhDC pro-
moter may reflect declining nutrient bioavailability or altered
physiological environments. For instance, the rapid production
of the large IBC biomass probably does not result in a signif-
icant production of acid resulting in a lower pH, since flhDC
FIG. 5. Competitive infection of a prototypic cystitis strain, UTI89, and a nonmotile UPEC strain, UTI89 fliC, in the bladders and kidneys
of mice. (A) Mice were transurethrally inoculated with either UTI89 or UTI89 fliC, and CFU in the bladders (F) and kidneys (E) was enumerated
2 weeks postinfection. (B) Mice were inoculated with a mixed inoculum (1:1 ratio) of both UTI89 and UTI89 fliC, and CFU were enumerated
in bladders and kidneys by replica plating onto LB or LB-kanamycin (50 g/ml) plates 2 weeks postinfection. The CI of bacteria recovered from
the organs were calculated as described in Materials and Methods. Horizontal bars indicate the geometric mean titer or CI of the sample group
indicated (n  5 mice per strain). During the competitive infection, recovery of UTI89 fliC was significantly lower in the bladder (P  0.008 by
the Mann-Whitney U test), indicating a competitive disadvantage during persistent cystitis, while a trend toward significance in the kidney was seen
(P  0.1 by the Mann-Whitney U test).
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expression is reported to be repressed by low pHs (49). How-
ever, the comprehensive signals required for expression of the
later gene products do not seem to be present in vivo, such that
flagellar regulon activation is delayed or stops early in the
hierarchy.
Both CsrA and DnaK have been shown to play roles in
regulating flagella (9, 28, 44). CsrA plays a central role as a
carbon storage regulator but has multiple effects on the regu-
lation of biofilm-associated proteins such as flagella (9, 28). It
has been shown that mutations in dnaK result in decreased
expression of flhDC, causing a nonmotile phenotype (44). Late
IBC formation is temporally associated with neutrophil infil-
tration and epithelial cell death, both contributing to potential
oxidative stress in the bacteria. Reactive oxygen species have
been shown to reversibly decrease levels of DnaK while up-
regulating Hsp33 (52). Thus, it is possible that under the stress
from host factors, DnaK becomes titrated, resulting in dysregu-
lation of flagellar expression. Similarly, changes in carbon
availability in vivo but not in vitro may affect the CsrA pathway
and account for the results observed.
The incomplete regulatory circuit from class I to class III
activation may reflect the conservation of resources, since pro-
duction and powering of this organelle may divert important
assets from otherwise essential activities. Alternatively, only
the hook and basal body may be expressed as part of a viru-
lence program. Since flagella are thought to be evolutionary
relatives of type III secretion systems, the hook and basal body
could produce a structure analogous to a secretion pore
through which bacterial effectors interact with the host cell to
promote IBC development and maintenance. Further studies
will elucidate whether the hook and basal body are produced
and functional during IBC formation.
The flagella of EPEC (12) and Salmonella spp. (43, 51)
function not only in motility but also as adhesive and invasive
organelles, respectively, to adhere to epithelial cells and pro-
mote biofilm formation (39, 40). However, the nonmotile
UTI89 fliC produced IBCs similar in number and morphol-
ogy to those formed by UTI89 at all time points examined,
suggesting that the flagellar filament does not function as an
adhesive organelle to aggregate bacteria within the IBC. Fur-
thermore, the filament was not required for invasion, as evi-
denced by the fact that bacteria were observed intracellularly.
These results are consistent with the minimal expression or
lack of expression of fliC in IBCs. The 30-h UTI89 fliC IBCs
observed may be first-generation IBCs halted from progress-
ing, or UPEC may disperse from an IBC by an alternative
mechanism. Without flagellum-mediated dispersal and fluxing,
nonmotile bacteria could be passively released by cell death
and deterioration of eukaryotic cellular membranes during
exfoliation in response to infection. This mechanism is sup-
ported by the lack of gfp expression or minimal gfp expression
from the class III-gfp reporter in early, mid-, and late IBCs in
contrast to its robust activity under in vitro conditions favor-
able to motility. However, when mice were infected simulta-
neously with wild-type UTI89 and UTI89 fliC at a ratio of 1:1,
20-fold and 300-fold-lower titers in the bladder and kidney,
respectively, were seen for the nonmotile fliC-negative mutant
relative to the motile parent strain. Thus, a fliC deletion mu-
tant had a competitive disadvantage in both the bladder and
the kidneys 2 weeks postinfection, suggesting a role for flagella
in the pathogenic cascade downstream of IBC formation. Sim-
ilar results were obtained using UPEC CFT073 in the CBA
mouse model of UTI (14); whereas the CFT073 fliC mutant
was able to colonize the bladder to levels not significantly
different from those of the wt in single infections, wild-type
CFT073 outcompeted a fliC mutant in cochallenge experi-
ments (24).
In contrast to the known UPEC virulence factor, type 1 pili,
which are up-regulated to promote virulence, we hypothesize
flagella to be a UPEC virulence factor which is primarily down-
regulated in the urinary tract environment. The concept of
negatively regulating a virulence factor as a function of envi-
ronment is a known mechanism in Haemophilus influenzae,
which down-regulates HMW1 for immune system evasion in
the inner ear (8). Flagellin from many bacterial species, includ-
ing E. coli, elicits a strong proinflammatory activity by epithe-
lial cells, which in turn promotes bacterial clearance by innate
host defenses (3, 29, 32, 53, 54). Down-regulation of flagella at
appropriate times may provide UPEC an additional defense
mechanism that contributes to persistence within the urinary
tract. Induction of flagellar expression in response to specific
environmental cues may provide motile bacteria with subtle
advantages.
Concluding remarks. Flagella have been established as an
important virulence factor in numerous bacterial pathogenesis
models, but their requirement and specific role in UTI have
not been elucidated previously, particularly in light of the re-
cent description of IBCs and their dispersal. The paradigm of
UTI pathogenesis, an ascending infection against the counter-
current of urinary flow, suggests an overt and even essential
role for flagella in producing disease. However, the studies
described in this report suggest that the role is subtle. In
support of a subtle role for flagella in UPEC pathogenesis are
the recent reports by Bahrani-Mougeot et al. and Snyder et al.
(2, 46). Signature-tagged mutagenesis screens in an ascending
UTI mouse model and transcriptome microarray gene profil-
ing of bacteria recovered from the urine of mice with active
UTI failed to identify flagella as a key virulence factor. In fact,
transcriptome profiling demonstrated flagella and chemotaxis
genes to be down-regulated in vivo, further supporting the
results presented in this study. While nonmotile UPEC can
unmistakably advance through the stages of UTI in both the
bladder and the kidney, the studies reported here clearly show
that bacteria with the full capacity to produce flagella are at a
competitive advantage in both the bladder and the kidney,
although the mechanism by which this advantage is conferred
is still unclear. Notably, our study of flagellar expression during
the course of IBC development has revealed the first in vivo
example of the checkpoints present in flagellar production,
previously detailed through in vitro genetic studies. The ex-
pression of selective gene classes in vivo may provide impor-
tant leads regarding the physiological states of the IBC and the
host epithelial cell.
Studies of the roles of flagella in UPEC UTI pathogenesis
may need to be revisited if true models of ascension are to be
developed. Since most UPEC strains are motile, flagellar func-
tion appears to be evolutionarily conserved. Perhaps the role
of flagella is in maintenance in the enteric or genitourinary
tracts, allowing emergence into the periurethral region and
ascent into the urethra for the initiation of UTI. Flagella may
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also have a role in dissemination from the urinary tract in
urosepsis or in the ascension from the bladder to the kidneys.
Only true models of UPEC recirculation between extraurinary
sites of colonization and the urinary tract will serve to answer
these questions.
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